MHRA

Share

MHRA

 •  October 23

MHRA is releasing the response to January’s consultation on the strategy for pharmacopoeial public quality standards for biological medicines In January 2017, MHRA launched a public consultation on pharmacopoeial quality standards for biological medicines. The quality of biological medicines, which are an increasingly important part of healthcare...

MHRA

 •  October 10

For science, research, and innovation to provide solutions to global health challenges, people and ideas need to be able to come together to make a difference, Dr Jeremy Farrar OBE, Director of the Wellcome Trust said at the 12th Annual Lecture organised by the Medicines and Healthcare products Regulatory Agency in London tonight, 10 October...

MHRA

 •  September 20

The UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) brought together experts from across the sector to discuss some hot topics and important developments that are having an impact on the changing and dynamic UK life sciences ecosystem. Through a series of presentations, panel discussions and Q and...

MHRA

 •  September 19

In collaboration with key stakeholders, MHRA has produced guidance on the human factors aspects of design for medical devices including those in drug-device combination products. This guidance is intended for manufacturers, developers and notified bodies to highlight the important influence human factors have on patient safety. The advice is also...

MHRA

 •  September 18

The Medicines and Healthcare products Regulatory Agency is conducting a survey to better understand how it can support its customers As part of our continued commitment to deliver a high-quality service to our customers, stakeholders and partners, the Medicines and Healthcare products Regulatory Agency is embarking on a major operational...

MHRA

 •  August 29

From sticking plasters to hip replacements, contact lenses to implanted pacemakers, medical devices are a part of everyday life. To make sure these medical devices are acceptably safe and perform as intended, they must comply with the relevant EU legislation. The Medicines and Healthcare products Regulatory Agency (MHRA) has created an introductory...

MHRA

 •  August 24

People with diabetes who use NovoPen® Echo® and NovoPen® 5 should check to see if their devices are included in the company-led recall by Novo Nordisk. The insulin cartridge holder in certain batches may crack or break resulting in an under-delivery of insulin which can lead to high blood glucose (hyperglycaemia) and can have serious health...

MHRA

 •  August 22

The Medicines and Healthcare products Regulatory Agency (MHRA) is warning people to not use or buy Hightop HIV/AIDS Home Test Kit after seizing 114 potentially unreliable products from 2 UK based suppliers. If you believe you have used a Hightop HIV/AIDS Home Test Kit you should seek a further HIV test at your local sexual health clinic or through...

MHRA

 •  June 20

We are delighted that the chair of the Medicines and Healthcare products Regulatory Agency (MHRA), Professor Sir Michael Rawlins, has been appointed Knight Grand Cross of the Order of the British Empire (GBE). The honour, which was announced in the 2017 Birthday Honours List over the weekend, is for services to the safety of medicines, healthcare...

MHRA

 •  February 27

The stem cell lines are produced and quality-controlled under European regulation and are therefore suitable for use as starting materials in manufacturing therapies for clinical trials, saving researchers precious time and effort. The UKSCB is a world leading not-for-profit pluripotent stem cell bank distributing stem cell lines qualified for use...